Studies Prevention of upper respiratory tract infections in high performance athletes with Plesinox 3A. See PDF Clinical experience with Plesinox in recurrent infections referred for ent consultations. See PDF Evaluation of the activity of EPL and EPL+vitamins in human peripheral blood monocyte-macrophage cells. See PDF Immunomodulatory effect of Polypodium leucotomos (Anapsos) in child palatine tonsil model. See PDF Tonsillopharyngitis chronic in children. Reply with anapsos. See PDF Anapsos use in the treatment of chronic recurrent pharyngo-tonsillitis. See PDF Assessment of anapsos activity in children with pharyngotonsillitis by reducing the number of tonsillectomy. See PDF New clinical experience with Plesinox 3A in recurrent pediatric pathology with special attention to PFAPA syndrome. See PDF Distributed by: Especialidades Farmacéuticas CENTRUM, S.A. RGSEAA: 26.09272/A C/ Sagitario, 14. 03006 Alicante – España